Arlington Capital Management’s Nuveen Corporate Income November 2021 Target Term Fund JHB Stock Holding History

Arlington Capital Management’s Portfolio JHB Stock Details JHB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-153,401	Closed	-$1.44M	–	99
2021 Q3	$1.44M	Buy	153,401 +15,942	+12%	+$150K	2.69%	15
2021 Q2	$1.29M	Buy	137,459 +40,751	+42%	+$383K	2.6%	10
2021 Q1	$906K	Buy	96,708 +50,143	+108%	+$467K	1.66%	21
2020 Q4	$428K	Buy	+46,565	New	+$424K	0.58%	41
2020 Q2	–	Sell	-45,231	Closed	-$389K	–	65
2020 Q1	$389K	Sell	45,231 -1,719	-4%	-$16.5K	0.36%	31
2019 Q4	$470K	Sell	46,950 -13,022	-22%	-$130K	0.29%	37
2019 Q3	$593K	Buy	59,972 +38,401	+178%	+$381K	0.36%	31
2019 Q2	$214K	Buy	+21,571	New	+$212K	0.12%	39

Arlington Capital Management's JHB Position: Q4 2021 in Review

Arlington Capital Management sold out of Nuveen Corporate Income November 2021 Target Term Fund (JHB) in Q4 2021, closing a stake of 153,401 shares — an estimated $1.44M sold.

Arlington Capital Management first reported a position in JHB in Q2 2019 and held it in 8 quarters. The position peaked at $1.44M in Q3 2021. 0 funds tracked by Wall St. Rank hold JHB as of Q4 2021.

Arlington Capital Management reported no remaining Nuveen Corporate Income November 2021 Target Term Fund position as of Q4 2021 after selling out during the quarter.
Arlington Capital Management sold 153,401 Nuveen Corporate Income November 2021 Target Term Fund shares in Q4 2021, an estimated $1.44M.
Arlington Capital Management first reported a position in Nuveen Corporate Income November 2021 Target Term Fund in Q2 2019 and held it in 8 quarters.
Arlington Capital Management's Nuveen Corporate Income November 2021 Target Term Fund position peaked at $1.44M in Q3 2021.
0 funds tracked by Wall St. Rank held Nuveen Corporate Income November 2021 Target Term Fund as of Q4 2021.

Based on Arlington Capital Management's 13F filing for Q4 2021, filed 31 Jan 2022.